Cogent Biosciences, Inc. (COGT) vs RadNet, Inc. (RDNT)

A side-by-side comparison of Cogent Biosciences, Inc. and RadNet, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — COGT vs RDNT

growth of $100 · dividends reinvested · last 9y
COGT -30.5% (-4.0%/yr)RDNT +390.1% (+19.3%/yr)RDNT compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $1002020202220242026$69$490
COGT RDNT

COGT vs RDNT: by the numbers

  • •RDNT is the larger company ($5.53B vs $5.19B market cap).
  • •Both run net losses; COGT's is the smaller (0.00% vs -0.93% net margin).

Metrics side by side

Valuation

MetricCOGTRDNT
Forward P/EN/A136.65
P/S ratioN/A2.44
P/B ratio11.105.04
EV / EBITDAN/A21.70

Profitability

MetricCOGTRDNT
Gross margin0.00%9.70%
Operating margin0.00%4.00%
Net margin0.00%-0.93%
ROE-70.85%-1.93%
ROIC-50.09%1.41%

Growth (annualized)

MetricCOGTRDNT
Revenue CAGR (5Y)N/A12.68%
Total return CAGR (5Y)28.51%19.72%

Frequently asked

How have COGT and RDNT total returns compared?
Over the past 5 years, COGT delivered 28.51% and RDNT delivered 19.72% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.